Effects of Acupressure applied by midwives on pregnant women, after Delivery, and for assessing newborn Outcomes at LI4, GB21, and SP6 Acupoints among Women during the First Stage of Labor.

Effects of Midwife-Centered Acupressure (MID-CURE) at LI4, GB21 and SP6 points on Maternal, Delivery and Neonatal outcome among primi-parturient women during first stage of labour admitted in Tertiary care hospital: A Double-Blinded Randomized Sham Controlled Clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084699

Enrollment

292

Registered

2025-04-13

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Midwife Centered Acupressure (MID-CURE)- LI4 point, GB21 point, SP6 point: Midwife Centered Acupressure (MID-CURE): Midwife acupressure involves using specific acupressure techniques d

Eligibility

Inclusion criteria

Inclusion criteria: Primi parturient women in spontaneous labour with intact membrane. In First stage of labour. Estimated fetal weight of 2.5 - 4 kgs. No Significant Medical History or past obstetrics history and without any pregnancy complications.

Exclusion criteria

Exclusion criteria: Primi-parturient women in use of Epidosin, or Tab Misoprost. Pregnancy after infertility. With Cognitive deficits or impairments. Refusal to continue participation in the study, receiving pain relief drugs 3 hours before or during the study, labour induction or enhancement by medication. during the study

Design outcomes

Primary

Measure	Time frame
1.To determine the efficacy of Midwife-centered acupressure (MID-CURE) on maternal, delivery, and neonatal outcome among primi-parturient women in the first stage of labour within and between LI4, GB21 and SP6 intervention groups and sham control groupTimepoint: 1 years	—

Secondary

Measure	Time frame
1. To estimate the maternal, delivery, and neonatal outcome among primi-parturient women before the application of MID-CURE at LI4, GB21 and SP6 intervention groups and sham control group 2. To determine the difference in maternal, delivery, and neonatal outcome among primi-parturient women after the application of at LI4, GB21 and SP6 intervention groups and sham control group 3. To determine association between maternal, delivery, and neonatal outcome among primi-parturient women in LI4, GB21 and SP6 intervention groups and sham control group with their selected variables. 4. To estimate the Satisfaction with MID-CURE among primi-parturient women after the application of at LI4, GB21 and SP6 intervention groups Timepoint: 3 years	—

Measure

Time frame

1. To estimate the maternal, delivery, and neonatal outcome among primi-parturient women before the application of MID-CURE at LI4, GB21 and SP6 intervention groups and sham control group 2. To determine the difference in maternal, delivery, and neonatal outcome among primi-parturient women after the application of at LI4, GB21 and SP6 intervention groups and sham control group 3. To determine association between maternal, delivery, and neonatal outcome among primi-parturient women in LI4, GB21 and SP6 intervention groups and sham control group with their selected variables. 4. To estimate the Satisfaction with MID-CURE among primi-parturient women after the application of at LI4, GB21 and SP6 intervention groups Timepoint: 3 years

—

Countries

India

Contacts

Public ContactDr Barkha Devi

Sikkim Manipal College of Nursing, Sikkim Manipal University

barkha.d@smims.smu.edu.in7479278673

Outcome results